# BridgeBio Pharma, Inc. Common Stock (BBIO)

BridgeBio Pharma's stock surges to a 52-week and all-time high following highly positive Phase [--] results for BBP-418, despite some concerns about European patent issues and company debt.

### About BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma, Inc. Common Stock (BBIO) is a publicly traded stock in the healthcare sector focused on developing innovative medicines.  
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- BridgeBio Pharma, Inc. Common Stock (BBIO) social dominance hit [----] which is 125% higher than it's daily average.
- BridgeBio Pharma, Inc. Common Stock (BBIO) creators hit [---] which is 146% higher than it's daily average.
- BridgeBio Pharma, Inc. Common Stock (BBIO) trading volume is up 155.19% from the previous year.
- BridgeBio Pharma, Inc. Common Stock (BBIO) market cap is up 10.58% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) social dominance is up 469.44% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) Galaxy Score™ is up 60.61% from the previous [--] months.
- BridgeBio Pharma, Inc. Common Stock (BBIO) sentiment is up 71.7% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) creators is up 132.91% from the previous month.
- BridgeBio Pharma, Inc. Common Stock (BBIO) engagements is up 200.19% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) mentions is up 119% from the previous month.
- BridgeBio Pharma, Inc. Common Stock (BBIO) posts created is up 810% from the previous week.
- BridgeBio Pharma, Inc. Common Stock Price hit a 52-Week high of $88 for the hour
- BridgeBio Pharma, Inc. Common Stock Price hit an all time of $88 for the hour

### Price: $75.30
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/close.tsv)  
The stock price has surged to a 52-week and all-time high, driven by highly positive Phase [--] results for BBP-418 and strong market performance, despite some concerns about European patent issues and company debt.  

24-Hour: -1.06%
7-Day: 10.58%
30-Day: -1.32%

1-Year High: $79.90 on 2026-01-22  
1-Year Low: $30.10 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/alt_rank.tsv)  
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #361 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] [----]  
[--] Month: [---] [----]  
[--] Months: [---] [----]  
[--] Year: [---] +197  
1-Year High: [-----] on 2026-01-26  
1-Year Low: [--] on 2025-05-17  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +17  
[--] Month: [--] +9  
[--] Months: [--] +18  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-12-08  
1-Year Low: [--] on 2025-12-25  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +200%  
[--] Month: [---------] +94%  
[--] Months: [---------] -13%  
[--] Year: [----------] +9.40%  
1-Year High: [-------] on 2025-02-20  
1-Year Low: [-----] on 2025-12-07  

Engagements by network (24h):
YouTube: [--]
X: [------]
News: [--]
TikTok: [--]
Reddit: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] +98%  
[--] Month: [-----] +119%  
[--] Months: [-----] +0.90%  
[--] Year: [-----] +45%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
YouTube: [--]
X: [---]
News: [--]
TikTok: [--]
Reddit: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last [--] hours which is up 0.44% from [---] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +82%  
[--] Month: [---] +133%  
[--] Months: [-----] -11%  
[--] Year: [-----] +89%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-10-12  

The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]    | [------]      |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | [--]    | [------]    | [--]     | [-----]       |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]    | [-----]       |
| [@stocksrockman](/creator/twitter/stocksrockman)     | [--]    | [-----]     | [--]     | [-----]       |
| [@Pharmdca](/creator/twitter/Pharmdca)               | [--]    | [-------]   | [--]     | [-----]       |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | [--]    | [------]    | [--]     | [---]         |
| [@BioStocks](/creator/twitter/BioStocks)             | [--]    | [-------]   | [--]     | [---]         |
| [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | [--]    | [-----]     | [--]     | [---]         |
| [@DwightS2025](/creator/twitter/DwightS2025)         | [--]    | [---]       | [--]     | [---]         |
| [@OptionRunners](/creator/twitter/OptionRunners)     | [--]   | [------]    | [--]     | [---]         |

[View More](/list/creators/$bbio/100)
  
  
### Sentiment: 87%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/sentiment.tsv)  
Current Value: 87%  
Daily Average: 77%  
[--] Week: 91% +38%  
[--] Month: 92% +30%  
[--] Months: 92% +14%  
[--] Year: 92% +23%  
1-Year High: 96% on 2025-10-06  
1-Year Low: 40% on 2025-05-28  

Most Supportive Themes:
- Positive Phase [--] Results for BBP-418: (50%) BridgeBio Pharma's drug for a muscle disorder, BBP-418, met its goals in a late-stage trial, leading to positive sentiment and stock price surges.
- Strong Market Performance and Increased Market Cap: (30%) The stock's price action is also attributed to the overall strong market performance and a significant increase in market capitalization.
  
Most Critical Themes:
- FDA Hold on Intellia Therapeutics: (10%) While not directly about BBIO, news of an FDA hold on a competitor like Intellia Therapeutics can impact overall biotech sentiment and investor focus.
- Debt and Cash Burn: (10%) Some posts mention the company's debt and cash burn, which could be a point of concern for investors despite positive trial results.
  
  
  
### Social Dominance: 0.025%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/social_dominance.tsv)  
Current Value: 0.025%  
Daily Average: 0.022%  
[--] Week: 0.062% +0.051%  
[--] Month: 0.05% +0.037%  
[--] Months: 0.05% +0.016%  
[--] Year: 0.05% +0.0092%  
1-Year High: 0.068% on 2025-06-28  
1-Year Low: 0.0058% on 2025-10-12  
  
  
### Market Dominance: 0.016%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/market_dominance.tsv)  
Current Value: 0.016%  
Daily Average: 0%  
1-Year High: 0.018% on 2026-01-02  
1-Year Low: 0.00849% on 2025-05-28  
  
  
### Market Cap: $14,419,930,847
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/market_cap.tsv)  
Current Value: $14,419,930,847  
Daily Average: $9,853,177,723  
[--] Week: $14,419,930,847 +11%  
[--] Month: $14,419,930,847 -1.30%  
[--] Months: $14,419,930,847 +54%  
[--] Year: $14,419,930,847 +117%  
1-Year High: $15,312,912,611 on 2026-01-22  
1-Year Low: $5,732,285,188 on 2025-04-08  

### Top BridgeBio Pharma, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"No update for a bit lets talk: This year Im modifying my approach and will be focusing on high conviction plays and holding a significant cash stack. I am about 70% cash currently and holding onto it for good opportunities. I closed a vast majority of my positions but I wont spend too much time on those in this post. Here is where I currently stand: Long: $BBIO $CRNX $SLNO These are long term holds. I intend to hold onto both $BBIO and $CRNX for years to come and I think both have fantastic potential as long as they continue to execute. $BBIO is my largest position by quite a bit and I have"  
[X Link](https://x.com/augurbio/status/2022508788771651926) [@augurbio](/creator/x/augurbio) 2026-02-14T03:10Z [---] followers, [---] engagements


"whos got better beef $ASND v $BBIO or $EYPT v $OCUL"  
[X Link](https://x.com/PersimmonTI/status/2022443208840745363) [@PersimmonTI](/creator/x/PersimmonTI) 2026-02-13T22:50Z 10.9K followers, [----] engagements


"$BAX -Barclays lowers Baxter target to $25 from $30 Overweight -Jefferies lowers target to $19 from $21 Hold - $BBIO -Wells Fargo raises BridgeBio Phara target to $98 from $88 Overweight -Oppenheimer raises target to $83 from $81 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2022400585635655875) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-13T20:00Z [----] followers, [---] engagements


"$NXXT +250% revenue growth indicates compounding trajectory. $BBIO $VKTX $IPGP $IRDM"  
[X Link](https://x.com/houssein_walid/status/2022382250529296442) [@houssein_walid](/creator/x/houssein_walid) 2026-02-13T18:47Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing